Brachytherapy provider Imagyn Medical Technologies has completed the sale of its minimal access surgery (MAS) product lines to Conmed. The transaction was valued at approximately $33.9 million, according to Irvine, CA-based Imagyn. The sale completes a 18-month strategy to transform Imagyn from a company that makes primarily laparoscopic and related products into a provider of diagnostic and treatment devices for use in oncology and critical care, according to the vendor.
By AuntMinnie.com staff writersJuly 10, 2001
Related Reading
Imagyn divests MAS assets, June 12, 2001
Imagyn buys Intl. Isotopes brachytherapy assets, May 1, 2001
Theragenics adds deal with Imagyn, September 22, 2000
Copyright © 2001 AuntMinnie.com
